Glenmark launches Akynzeo IV in India EP News Bureau Jan 23, 2023 It's the first fixed IV anti-emetic combination for the prevention of chemotherapy-induced nausea and vomiting
Glenmark launches sacubitril+valsartan tablets in India to treat heart failure EP News Bureau Jan 17, 2023 The launch of the tablets under the brand name, Sacu V, brings down the cost of treatment for heart failure
Glenmark gets ANDA approval for Nicardipine Hydrochloride Capsules, 20 mg and 30 mg EP News Bureau Dec 19, 2022 Nicardipine tablets are indicated for the treatment of high blood pressure and to control angina (chest pain)
USFDA issues import alert on Glenmark Pharma’s Baddi plant Press Trust of India Oct 27, 2022 As per the USFDA, import alert 66-40 implies detention without physical examination of drugs from firms which have not met drug…
In a first, Glenmark launches Lobeglitazone in India for uncontrolled type-II diabetes in adults EP News Bureau Oct 6, 2022 With this launch, the company aims to improve glycemic levels in uncontrolled diabetics and create a new pathway to treat insulin…
Health Canada approves Ryaltris for treatment of Seasonal Allergic Rhinitis EP News Bureau Sep 26, 2022 Ryaltris is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one…
Sun Pharma, Glenmark recall drugs in US due to manufacturing deviations Press Trust of India Jul 25, 2022 Sun Pharma is recalling 50,680 vials of Testosterone Cypionate Injection, while Glenmark is recalling 98,307 packs of Mometasone…
Glenmark Pharma and SaNOtize announce results of its phase-III clinical trials on SaNOtize’s Nitric… EP News Bureau Jul 15, 2022 The trial administered to adult COVID-19 patients in India met the key endpoints and demonstrated reductions of viral load of 94…
Glenmark raises industry’s first sustainability-linked loan of $228 million Press Trust of India Mar 24, 2022 Bank of America, the sole underwriter of the entire loan, has extended $50 million, and Cincinnati, Ohio-based Fifth Third Bank…
Glenmark gets US FDA nod for nasal spray to treat seasonal allergic rhinitis Press Trust of India Jan 14, 2022 With this NDA approval, the company looks forward to bringing this new medicine to physicians and their patients for the treatment…